Nicholas Company’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $80.1M | Hold |
159,828
| – | – | 1.47% | 15 |
|
|
2026
Q1 | $78.6M | Sell |
159,828
-140
| -0.1% | -$76K | 1.54% | 13 |
|
|
2025
Q4 | $92.7M | Hold |
159,968
| – | – | 1.62% | 8 |
|
|
2025
Q3 | $77.6M | Buy |
159,968
+24,990
| +19% | +$11.6M | 1.32% | 15 |
|
|
2025
Q2 | $54.7M | Hold |
134,978
| – | – | 0.92% | 43 |
|
|
2025
Q1 | $67.2M | Hold |
134,978
| – | – | 1.16% | 26 |
|
|
2024
Q4 | $70.2M | Hold |
134,978
| – | – | 1.14% | 25 |
|
|
2024
Q3 | $83.5M | Buy |
134,978
+20
| +0% | +$11.8K | 1.36% | 14 |
|
|
2024
Q2 | $74.6M | Hold |
134,958
| – | – | 1.24% | 16 |
|
|
2024
Q1 | $78.4M | Buy |
134,958
+10
| +0% | +$5.61K | 1.3% | 15 |
|
|
2023
Q4 | $71.6M | Hold |
134,948
| – | – | 1.27% | 12 |
|
|
2023
Q3 | $68.3M | Sell |
134,948
-245
| -0.2% | -$131K | 1.37% | 12 |
|
|
2023
Q2 | $70.5M | Hold |
135,193
| – | – | 1.35% | 14 |
|
|
2023
Q1 | $77.9M | Hold |
135,193
| – | – | 1.58% | 5 |
|
|
2022
Q4 | $74.4M | Sell |
135,193
-20
| -0% | -$10.6K | 1.59% | 8 |
|
|
2022
Q3 | $68.6M | Hold |
135,213
| – | – | 1.57% | 9 |
|
|
2022
Q2 | $73.5M | Sell |
135,213
-51
| -0% | -$28.1K | 1.6% | 8 |
|
|
2022
Q1 | $79.9M | Sell |
135,264
-6,025
| -4% | -$3.46M | 1.43% | 10 |
|
|
2021
Q4 | $94.3M | Sell |
141,289
-34,760
| -20% | -$21.7M | 1.53% | 8 |
|
|
2021
Q3 | $101M | Sell |
176,049
-30
| -0% | -$16.5K | 1.77% | 4 |
|
|
2021
Q2 | $88.8M | Sell |
176,079
-3,395
| -2% | -$1.6M | 1.56% | 5 |
|
|
2021
Q1 | $81.9M | Sell |
179,474
-450
| -0.3% | -$215K | 1.53% | 9 |
|
|
2020
Q4 | $83.8M | Sell |
179,924
-55,465
| -24% | -$26M | 1.59% | 7 |
|
|
2020
Q3 | $104M | Sell |
235,389
-5,045
| -2% | -$2.08M | 2.19% | 4 |
|
|
2020
Q2 | $87.1M | Buy |
240,434
+10
| +0% | +$3.35K | 2% | 5 |
|
|
2020
Q1 | $68.2M | Sell |
240,424
-30,260
| -11% | -$9.54M | 1.93% | 5 |
|
|
2019
Q4 | $87.9M | Sell |
270,684
-315
| -0.1% | -$95.5K | 1.85% | 6 |
|
|
2019
Q3 | $78.9M | Sell |
270,999
-80,415
| -23% | -$23M | 1.78% | 5 |
|
|
2019
Q2 | $103M | Sell |
351,414
-20,155
| -5% | -$5.55M | 2.3% | 3 |
|
|
2019
Q1 | $102M | Sell |
371,569
-12,090
| -3% | -$3.01M | 2.41% | 2 |
|
|
2018
Q4 | $85.9M | Sell |
383,659
-200
| -0.1% | -$46.9K | 2.24% | 2 |
|
|
2018
Q3 | $93.7M | Sell |
383,859
-59,195
| -13% | -$13.6M | 2.05% | 5 |
|
|
2018
Q2 | $91.8M | Sell |
443,054
-103,705
| -19% | -$22M | 2.14% | 5 |
|
|
2018
Q1 | $113M | Sell |
546,759
-28,780
| -5% | -$6.04M | 2.57% | 1 |
|
|
2017
Q4 | $109M | Sell |
575,539
-4,000
| -0.7% | -$766K | 2.38% | 1 |
|
|
2017
Q3 | $110M | Sell |
579,539
-15,405
| -3% | -$2.79M | 2.44% | 1 |
|
|
2017
Q2 | $104M | Buy |
594,944
+1,540
| +0.3% | +$259K | 2.31% | 2 |
|
|
2017
Q1 | $91.1M | Sell |
593,404
-79,890
| -12% | -$12.2M | 2.07% | 7 |
|
|
2016
Q4 | $95M | Sell |
673,294
-69,990
| -9% | -$10.3M | 2.12% | 9 |
|
|
2016
Q3 | $118M | Sell |
743,284
-296,445
| -29% | -$45.7M | 2.6% | 6 |
|
|
2016
Q2 | $154M | Buy |
1,039,729
+6,930
| +0.7% | +$1.02M | 3.1% | 2 |
|
|
2016
Q1 | $146M | Sell |
1,032,799
-12,690
| -1% | -$1.7M | 2.97% | 4 |
|
|
2015
Q4 | $148M | Buy |
1,045,489
+31,830
| +3% | +$4.25M | 2.77% | 5 |
|
|
2015
Q3 | $124M | Sell |
1,013,659
-96
| -0% | -$12.5K | 2.35% | 8 |
|
|
2015
Q2 | $132M | Buy |
1,013,755
+31,165
| +3% | +$4.06M | 2.3% | 10 |
|
|
2015
Q1 | $132M | Sell |
982,590
-351
| -0% | -$45.2K | 2.49% | 6 |
|
|
2014
Q4 | $123M | Buy |
982,941
+16,965
| +2% | +$2.06M | 2.52% | 7 |
|
|
2014
Q3 | $118M | Hold |
965,976
| – | – | 2.76% | 5 |
|
|
2014
Q2 | $114M | Sell |
965,976
-375
| -0% | -$44.1K | 2.71% | 6 |
|
|
2014
Q1 | $116M | Buy |
966,351
+15,550
| +2% | +$1.85M | 2.8% | 4 |
|
|
2013
Q4 | $106M | Sell |
950,801
-11,100
| -1% | -$1.1M | 2.57% | 5 |
|
|
2013
Q3 | $88.6M | Buy |
961,901
+15,965
| +2% | +$1.44M | 2.37% | 8 |
|
|
2013
Q2 | $80.1M | Buy |
+945,936
| New | +$78.7M | 2.45% | 6 |
|
Other funds holding TMO
Nicholas Company's TMO Position: Q2 2026 in Review
Nicholas Company held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 159,828 shares worth $80.1M. The position accounts for 1.47% of the portfolio, ranked #15.
Nicholas Company first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $154M in Q2 2016. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Nicholas Company held 159,828 shares of Thermo Fisher Scientific worth $80.1M as of Q2 2026.
- Nicholas Company left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 1.47% of Nicholas Company's portfolio in Q2 2026, its #15 holding.
- Nicholas Company first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Nicholas Company's Thermo Fisher Scientific position peaked at $154M in Q2 2016.
- 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Nicholas Company's 13F filing for Q2 2026, filed 5 Aug 2026.